[Current status and future prospects in the treatment of acute-phase cerebral infarction].
Yamaguchi
T
T
D000210:Acute-Phase Reaction; D001241:Aspirin / Q000627:therapeutic use; D001929:Brain Edema / Q000209:etiology / Q000517:prevention & control; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002544:Cerebral Infarction / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007036:Hypothermia, Induced; D008353:Mannitol / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D008353:Mannitol; D010959:Tissue Plasminogen Activator; D001241:Aspirin